Literature DB >> 24312755

Novel PH Sensitive Nanocarrier Agents Based on Citric Acid Dendrimers Containing Conjugated β-Cyclodextrins.

Hassan Namazi1, Yousef Toomari Hamrahloo.   

Abstract

INTRODUCTION: In this work, the use of β-cyclodextrine (β-CD)-modified dendrimers as a nanocapsule with a biocompatible shell have studied. β-CD-modifieddendrimers have designed and synthesized to enhance the loading capacity of the final dendrimers with encapsulation properties.
METHODS: To achieve β-CD-modified dendrimers, first citric acid dendrimers were synthesized and then the end functional groups of dendrimers were grafted to β-CD through ester linkages. The molecular structures of resulted dendrimers were verified using common spectroscopic methods such as 1H NMR, FT-IR and the diameters of obtained nanocarriers were evaluated with using dynamic light scattering (DLS) experiments. The isolated dendrimers were utilized as the drug delivery agents and the encapsulation and the controlled release of guest drug molecule Naltrexone (NLX) was investigated in different pH's using UV spectroscopy method.
RESULTS: It was established that the loading capacity of dendrimers depend on several factors such as their generation and the structure and number of conjugated modifier end groups.
CONCLUSION: Increasing in the number of branches and the size of interior voids and number of conjugated β-CDs cause to enhance the loading capacity.

Entities:  

Keywords:  Citric acid; Dendrimer; Encapsulation; Naltrexone; Nanocarrier; β-Cyclodextrin

Year:  2011        PMID: 24312755      PMCID: PMC3850000          DOI: 10.5681/apb.2011.006

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  19 in total

1.  Complexation Thermodynamics of Cyclodextrins.

Authors:  Mikhail V. Rekharsky; Yoshihisa Inoue
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Introduction and General Overview of Cyclodextrin Chemistry.

Authors:  József Szejtli
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

3.  The Stability of Cyclodextrin Complexes in Solution.

Authors:  Kenneth A. Connors
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

Review 4.  Dendrimers in biomedical applications--reflections on the field.

Authors:  Sönke Svenson; Donald A Tomalia
Journal:  Adv Drug Deliv Rev       Date:  2005-11-21       Impact factor: 15.470

5.  Insulated molecular wires.

Authors:  Michael J Frampton; Harry L Anderson
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 6.  Dendrimers: novel polymeric nanoarchitectures for solubility enhancement.

Authors:  Umesh Gupta; Hrushikesh Bharat Agashe; Abhay Asthana; N K Jain
Journal:  Biomacromolecules       Date:  2006-03       Impact factor: 6.988

7.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

Authors:  R Esfand; D A. Tomalia
Journal:  Drug Discov Today       Date:  2001-04-01       Impact factor: 7.851

8.  Controlled release of linear-dendritic hybrids of carbosiloxane dendrimer: the effect of hybrid's amphiphilicity on drug-incorporation; hybrid-drug interactions and hydrolytic behavior of nanocarriers.

Authors:  Hassan Namazi; Saeed Jafarirad
Journal:  Int J Pharm       Date:  2011-01-14       Impact factor: 5.875

9.  Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

Authors:  D A Tomalia; L A Reyna; S Svenson
Journal:  Biochem Soc Trans       Date:  2007-02       Impact factor: 5.407

10.  Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines.

Authors:  Ismaeil Haririan; Mohammad Shafiee Alavidjeh; Mohammad Reza Khorramizadeh; Mehdi Shafiee Ardestani; Zohre Zarei Ghane; Hassan Namazi
Journal:  Int J Nanomedicine       Date:  2010-02-02
View more
  4 in total

1.  Fabrication of triblock ABA type peptide dendrimer based on glutamic acid dimethyl ester and PEG as a potential nano drug delivery agent.

Authors:  Hassan Namazi; Yousef Toomari; Hassan Abbaspour
Journal:  Bioimpacts       Date:  2014-11-22

2.  Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations.

Authors:  Seyedeh Masoumeh Ghoreishi; Ali Khalaj; Omid Sabzevari; Leila Badrzadeh; Pardis Mohammadzadeh; Seyed Shahaboddin Mousavi Motlagh; Ahmad Bitarafan-Rajabi; Mehdi Shafiee Ardestani
Journal:  Int J Nanomedicine       Date:  2018-08-15

3.  PEG-Citrate dendrimer second generation: is this a good carrier for imaging agents In Vitro and In Vivo?

Authors:  Pardis Mohammadzadeh; Mehdi Shafiee Ardestani; Sobhan Mortazavi-Derazkola; Ahmad Bitarafan-Rajabi; Seyedeh Masoumeh Ghoreishi
Journal:  IET Nanobiotechnol       Date:  2019-08       Impact factor: 1.847

4.  Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity.

Authors:  Artin Assadi; Vahideh Sharifi Najafabadi; Seyed Ataollah Sadat Shandiz; Azadah Shayeq Boroujeni; Sepehr Ashrafi; Ali Zaman Vaziri; Seyedeh Masoumeh Ghoreishi; Mohammad Reza Aghasadeghi; Seyed Esmaeil Sadat Ebrahimi; Morteza Pirali-Hamedani; Mehdi Shafiee Ardestani
Journal:  Onco Targets Ther       Date:  2016-09-07       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.